145544-50-9 Usage
Uses
Used in Pharmaceutical Research:
(S)-2-Amino-3-(4-tert-butoxycarbonylmethoxy-phenyl)-propionic acid is used as a chiral building block in pharmaceutical research for the development of new therapeutic agents. Its unique structure and optical activity contribute to the creation of novel drugs for various medical conditions.
Used in Organic Synthesis:
In the field of organic synthesis, (S)-2-Amino-3-(4-tert-butoxycarbonylmethoxy-phenyl)-propionic acid serves as a key component in the synthesis of complex organic molecules, leveraging its specific functional groups and stereochemistry.
Used in Peptide and Protein Chemistry:
(S)-2-Amino-3-(4-tert-butoxycarbonylmethoxy-phenyl)-propionic acid is also utilized in the study of peptide and protein chemistry, where its optical activity and chemical structure can be exploited to investigate the properties and functions of biological macromolecules.
Used in Material Science:
(S)-2-Amino-3-(4-tert-butoxycarbonylmethoxy-phenyl)-propionic acid has potential applications in the development of new materials, taking advantage of its unique chemical and physical properties.
Used in Biochemical Tools Development:
Furthermore, (S)-2-Amino-3-(4-tert-butoxycarbonylmethoxy-phenyl)-propionic acid can be employed in the creation of new biochemical tools, which may have applications in research, diagnostics, and therapeutics.
Check Digit Verification of cas no
The CAS Registry Mumber 145544-50-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,5,4 and 4 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 145544-50:
(8*1)+(7*4)+(6*5)+(5*5)+(4*4)+(3*4)+(2*5)+(1*0)=129
129 % 10 = 9
So 145544-50-9 is a valid CAS Registry Number.
145544-50-9Relevant academic research and scientific papers
Enantioselective synthesis of nonphosphorus-containing phosphotyrosyl mimetics and their use in the preparation of tyrosine phosphatase inhibitory peptides
Burke Jr., Terrence R.,Yao, Zhu-Jun,Zhao, He,Milne, George W. A.,Wu, Li,Zhang, Zhong-Yin,Voigt, Johannes H.
, p. 9981 - 9994 (2007/10/03)
Three new L-amino acid analogues 12, 18 and 25 have been prepared in protected form suitable for incorporation into peptides by solid-phase synthesis using Fmoc protocols. These agents represent nonphosphorus- containing phosphotyrosyl (pTyr) mimetics, wh
